Mexico's Government Launches Sputnik V Vaccine Production

The Russian Direct Investment Fund (RDIF) and the pharmaceutical company Laboratorios de Biológicos y Reactivos de México (BIRMEX), which the federal government owns, announced on July 5, 2021, the production of a test batch of the Sputnik V vaccine that will be used in Mexico's national vaccination program.

Mexico became the first country in North America to register Sputnik V and launch local production. 

To date, Sputnik V has been registered in 67 countries globally.

The Sputnik V vaccine is based on human adenoviral vectors and uses different vectors for the two vaccine doses. The price of Sputnik V is less than $10 per dose.

Kirill Dmitriev, CEO of the RDIF, commented in a new press release, “Sputnik V has been successfully used in Mexico for months demonstrating excellent safety and efficacy profile..... we strive to provide easier access to Sputnik V for the population of Mexico and help speed up the vaccination program.”

The Moscow-based Russian Direct Investment Fund is Russia's sovereign wealth fund established in 2011 to make equity co-investments.